Biocryst Pharmaceuticals (BCRX) Cash from Investing Activities: 2010-2015
Historic Cash from Investing Activities for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to -$3.0 million.
- Biocryst Pharmaceuticals' Cash from Investing Activities rose 94.37% to -$3.0 million in Q4 2015 from the same period last year, while for Dec 2015 it was -$18.0 million, marking a year-over-year increase of 54.97%. This contributed to the annual value of $52.6 million for FY2024, which is 140.00% up from last year.
- Biocryst Pharmaceuticals' Cash from Investing Activities amounted to -$3.0 million in Q4 2015, which was up 83.53% from -$18.1 million recorded in Q3 2015.
- Over the past 5 years, Biocryst Pharmaceuticals' Cash from Investing Activities peaked at $16.3 million during Q3 2011, and registered a low of -$53.1 million during Q4 2014.
- Moreover, its 3-year median value for Cash from Investing Activities was -$1.6 million (2013), whereas its average is -$5.1 million.
- The largest annual percentage gain for Biocryst Pharmaceuticals' Cash from Investing Activities in the last 5 years was 265.96% (2014), contrasted with its biggest fall of 2,246.95% (2014).
- Biocryst Pharmaceuticals' Cash from Investing Activities (Quarterly) stood at -$2.7 million in 2011, then surged by 235.44% to $3.6 million in 2012, then plummeted by 162.04% to -$2.3 million in 2013, then slumped by 2,246.95% to -$53.1 million in 2014, then soared by 94.37% to -$3.0 million in 2015.
- Its last three reported values are -$3.0 million in Q4 2015, -$18.1 million for Q3 2015, and $7.1 million during Q2 2015.